Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | HTT | P42858 | 3/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | HTR6 | P50406 | 2/20 | 0.37 |
| ▸ | HTR7 | P34969 | 1/20 | 0.37 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.35 |
| ▸ | BRD1 | O95696 | 1/20 | 0.35 |
| ▸ | BRPF1 | P55201 | 1/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
| ▸ | MMP13 | P45452 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12182024 | 0.86 | CYSLTR2 (0.40) | LMNAHTTSMN1; SMN2HTR6HTR7 | |
| SCHEMBL1353022 | 0.86 | HTR7 (0.48) | LMNAHTTHTR6HTR7SLC6A4 | |
| SCHEMBL4001032 | 0.81 | ALDH1A1 (0.41) | LMNAHTTTDP1L3MBTL1SLC6A4 | |
| SCHEMBL4655851 | 0.78 | LMNA (0.44) | LMNAHTTSMN1; SMN2L3MBTL1CA12 | |
| SCHEMBL4881596 | 0.77 | MAPT (0.42) | LMNASMN1; SMN2TDP1SLC6A4MAPT | |
| SCHEMBL4057724 | 0.77 | LMNA (0.43) | LMNAHTR6HTR7SLC6A4MAPT | |
| SCHEMBL580390 | 0.76 | CHRM2 (0.40) | LMNAHTTSMN1; SMN2TDP1L3MBTL1 | |
| SCHEMBL580013 | 0.76 | CHRM2 (0.40) | LMNAHTTSMN1; SMN2TDP1L3MBTL1 | |
| SCHEMBL580458 | 0.76 | CHRM2 (0.40) | LMNAHTTSMN1; SMN2TDP1L3MBTL1 | |
| SCHEMBL579971 | 0.76 | CYP24A1 (0.39) | LMNAHTTSMN1; SMN2TDP1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110086103-A1 | NOVEL MANDELATE SALT OF FESOTERODINE | ACTAVIS GROUP PTC EHF (IS) | 2011-04-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110086103-A1 | NOVEL MANDELATE SALT OF FESOTERODINE | BPHL, RAB27A, RPS27A | LMNA 4321/4885HTT 2826/4885SMN1; SMN2 827/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.